In the past few months, the CancerLinQ LLC team has been busy rolling out new products and onboarding practices through various extensions of CancerLinQ, the only oncology database developed by oncologists and for oncologists.
"The post-COVID world of medicine is a place of nuance at the new, tech-driven intersection of love and science," writes Dr. Douglas B. Flora of the virtual house call.
A hematologic oncologist for more than 20 years, Dr. Friedberg is currently director of the Wilmot Cancer Institute and Samuel Durand Professor of Medicine at the University of Rochester Medical Center in Rochester, NY.
For many of us, the necessity of social distancing during the COVID-19 pandemic has required us to get comfortable, fast, with technology, and there are lessons learned here that will be valuable even when the pandemic ends.
"The COVID-19 pandemic’s impact is immediate for people who suffered from infection, but there is also an indirect impact on people who had to defer diagnosis and treatment plans, and the consequences of these delays will likely last for years," Dr. Dawood Findakly writes.